Auro Laboratories (BOM:530233) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories Operating Cash Flow per Share?

Auro Laboratories's operating cash flow per share for the three months ended in Mar. 2025 was ₹0.00. Auro Laboratories's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Auro Laboratories was -69.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Auro Laboratories's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Auro Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 75.50% per year. The lowest was -29.30% per year. And the median was 13.10% per year.

BOM:530233's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Auro Laboratories Operating Cash Flow per Share Historical Data

The historical data trend for Auro Laboratories's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories Operating Cash Flow per Share Chart

Auro Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Operating Cash Flow per Share

Get a 7-Day Free Trial

20.56

-10.57

5.26

30.17

9.22

Auro Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Auro Laboratories's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Auro Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Auro Laboratories's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Auro Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Auro Laboratories's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Auro Laboratories Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Auro Laboratories's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2025 is calculated as

Operating Cash Flow per Share (A: Mar. 2025 )	=	Cash Flow from Operations (A: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2025 )
	=	57.471	/	6.233
	=	9.22

Auro Laboratories's Operating Cash Flow per Share for the quarter that ended in Mar. 2025 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	0	/	6.196
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Auro Laboratories Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Auro Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030

Website

http://www.aurolabs.com

Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines